Developer docs
API playgroundTry for free, no card

Search company profiles

Meridian Bioscience

Full company profile

uuid0003blh

Namestring
Meridian Bioscience
Legal namestring
Meridian Bioscience
Company typeenum
Private
Founded yearint
1981
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersCincinnati, United States
HQ citystring
Cincinnati
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostic reagents, qPCR master mixes, antigens and antibodies, in vitro diagnostics, immunoassay platforms
Industry2 codes
1Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
CodeHLAGAIAIPrimaryYes
2Molecular & Genetic Testing (PCR/NGS/qPCR)
CodeHLAGADAFPrimaryNo
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Laboratory Analytical Instruments3826
  • Services-Commercial Physical & Biological Research8731
  • Surgical & Medical Instruments & Apparatus3841
Product category
In Vitro Diagnostics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Molecular Reagents and Enzymes
TypeOne Time License
Description

Meridian offers molecular diagnostic reagents including qPCR master mixes, isothermal amplification reagents, NGS enzymes, and related enzymes sold to diagnostic manufacturers for incorporation into their test kits

meridianbioscience.com
2Antibodies and Antigens
TypeOne Time License
Description

Portfolio of over 3,000 antigens and antibodies covering more than 500 disease targets, sold to diagnostic manufacturers and assay developers

meridianbioscience.com
3Diagnostic Platforms and Tests
TypeHardware Sales
Description

Meridian manufactures and sells diagnostic platforms including molecular (Revogene, Alethia), immunoassay (Curian, Immunocard STAT), urea breath testing (BreathID), and blood chemistry (LeadCare) systems along with associated test reagents

meridianbioscience.com
4Contract Manufacturing Services
TypeProfessional Services
Description

Provides custom antibody and protein manufacturing services, and IVD contract manufacturing for diagnostic developers

meridianbioscience.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Meridian Bioline
Description

Trusted brand by leading molecular companies, antibody companies, and diagnostic manufacturers worldwide for human diagnostics, environmental testing, and veterinary diagnostics.

meridianbioscience.com
Core offering1 text field

Meridian Bioscience is a fully integrated life science company that develops, manufactures, and distributes diagnostic test kits and raw materials. The Life Science division supplies molecular reagents (qPCR/RT-qPCR master mixes, NGS enzymes, isothermal amplification reagents) and over 3,000 antigens and antibodies covering 500+ disease targets to diagnostic manufacturers. The Diagnostics division sells proprietary diagnostic platforms including Revogene, Alethia, BreathID, Curian, Immunocard, Premier, and LeadCare for clinical testing of gastrointestinal, respiratory, pediatric, and sexual health conditions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 12+ months ambient temperature stability for liquid master mixes
+1 more record
Product overview1 text field

Meridian Bioscience is a fully integrated life science and diagnostic company operating in over 70 countries. The company offers two main divisions: Life Science and Diagnostics. The Life Science division provides molecular and immunological reagents for diagnostic manufacturers, including over 3,000 antigens and antibodies covering more than 500 disease targets, specialty qPCR/RT-qPCR master mixes, molecular enzymes, nucleotides, and NGS reagents. The Diagnostics division offers diagnostic platforms and tests including molecular platforms (Revogene and Alethia), urea breath testing platforms (BreathID Hp Lab, BreathID Smart, BreathID Hp), immunoassay platforms (Curian, Immunocard STAT, Immunocard, Premier, Tru, Merifluor), and blood chemistry platforms (LeadCare). The product portfolio covers disease areas including gastrointestinal (H. pylori, C. difficile, rotavirus, adenovirus), respiratory (COVID-19, flu, pertussis, RSV), pediatric/neonatal (CMV, Group B Strep, lead poisoning), and sexual health (chlamydia, gonorrhea, HIV, HSV, HCV). Meridian's molecular reagents include liquid ambient-stable master mixes, lyophilization-ready (Lyo-Ready) and air-dryable formulations, specimen-specific inhibitor-tolerant mixes, and NGS library preparation solutions. All molecular reagents are manufactured under ISO13485 regulations.

Product and service21 records
1Revogene
CategoryMolecular diagnostic platform
Description

A molecular diagnostic platform used for respiratory and infectious disease testing, including a viral respiratory testing panel. Designed for clinical laboratories.

2Alethia
CategoryMolecular diagnostic platform
Description

A molecular diagnostic platform with IVDR-certified assays for pertussis, GBS, CMV, malaria, chlamydia, gonorrhea, and HSV 1&2. Sold to clinical laboratories and hospitals.

3BreathID Hp
CategoryUrea breath testing platform
Description

Urea breath testing platform for H. pylori diagnosis, used by hospitals and clinical laboratories.

4BreathID Smart
CategoryUrea breath testing platform
Description

Urea breath testing platform for point-of-care H. pylori detection.

5BreathID Hp Lab
CategoryUrea breath testing platform
Description

Urea breath testing platform for H. pylori detection in laboratory settings.

6Curian
CategoryImmunoassay platform
Description

Immunoassay diagnostic platform for clinical testing.

7Immunocard STAT
CategoryImmunoassay platform
Description

Immunoassay platform for rapid diagnostic testing.

8Immunocard
CategoryImmunoassay platform
Description

Immunoassay platform for diagnostic testing.

9Premier
CategoryImmunoassay platform
Description

Immunoassay diagnostic platform.

10Tru
CategoryImmunoassay platform
Description

Immunoassay platform for diagnostic testing.

11Merifluor
CategoryImmunoassay platform
Description

Immunoassay platform for diagnostic testing.

12LeadCare
CategoryBlood chemistry platform
Description

Blood lead testing platform for pediatric and environmental lead poisoning screening.

13Para-Pak
CategoryTransport and stain products
Description

Sample collection and transport products for diagnostics.

14Antibodies and Antigens Portfolio
CategoryImmunoreagents
Description

Over 3,000 antigens and antibodies covering more than 500 disease targets including allergens, autoimmune markers, cancer markers, infectious disease antigens, and more. Sold to diagnostic manufacturers and assay developers.

15Liquid Ambient-Stable Master Mixes
CategoryMolecular reagent
Description

qPCR master mixes including Liquid Stable Flex DNA qPCR Mix and Liquid Stable Ready DNA qPCR Mix, providing 12+ months ambient-temperature stability for diagnostic kit manufacturers.

16Specimen-Specific Inhibitor Tolerant Master Mixes
CategoryMolecular reagent
Description

Sample-specific qPCR and RT-qPCR formulations for direct amplification from crude lysates or inhibitor-rich samples including blood, saliva, urine, stool, and tissue.

17Lyo-Ready and Air-Dryable Master Mixes
CategoryMolecular reagent
Description

Glycerol-free formulations including Lyo-Ready qPCR Mix, Air-Dryable qPCR Mix, Lyo-Ready 1-Step RT-qPCR Mix, and Lyo-Ready LAMP Mix, compatible with lyophilization and air-drying for room temperature shipping.

18Isothermal Amplification Reagents
CategoryMolecular reagent
Description

LAMP, NASBA, and other isothermal amplification reagents including Bst DNA Polymerase for point-of-care diagnostics in resource-limited regions.

19Glycerol-Free NGS Enzymes
CategoryNGS reagent
Description

Glycerol-free enzymes for NGS library preparation enabling sequencing kits that can be shipped and stored at ambient temperature. Includes a Lyophilized NGS Library Preparation Kit with 12-month ambient stability.

20Molecular Enzymes
CategoryMolecular enzyme
Description

Includes Taq DNA Polymerase, MMLV-RT reverse transcriptase, and Glycerol-Free Taq HS DNA Polymerase for PCR/qPCR and reverse transcription applications.

21Custom Antibody and Protein Manufacturing Services
CategoryContract manufacturing services
Description

Custom antibody and protein manufacturing services, plus IVD contract manufacturing for diagnostic developers.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Meridian Bioscience and 4bases announced collaboration to enable rapid, globally scalable next-generation sequencing workflows. This partnership aims to advance molecular diagnostics capabilities through combined expertise in reagents and sequencing technologies.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Hologic is a molecular diagnostics company whose Panther system and assay menu compete with Meridian's Revogene and Alethia molecular diagnostic platforms in clinical laboratories for infectious disease testing.

TypeDirect peer
Description

Bio-Rad is a major manufacturer of molecular biology reagents, qPCR master mixes, and clinical diagnostics — directly comparable to Meridian's life science reagent and diagnostics businesses across both OEM and end-user channels.

TypeDirect peer
Description

QIAGEN is a global leader in molecular diagnostics and sample-prep reagents, directly competing with Meridian's PCR/qPCR reagents and NGS enzyme offerings and serving similar diagnostic manufacturer and laboratory customers.

TypeDirect peer
Description

NEB is a leading developer and manufacturer of molecular biology enzymes and reagents, including polymerases, master mixes, and isothermal amplification tools — a direct competitor to Meridian's molecular reagent portfolio.

TypeDirect peer
Description

Promega supplies molecular biology reagents, enzymes, and antibodies to life science researchers and diagnostic manufacturers, with overlapping product lines in qPCR reagents, NGS enzymes, and immunoassay components comparable to Meridian's offerings.

TypeDirect peer
Description

Cepheid's GeneXpert molecular diagnostic system competes directly with Meridian's Revogene platform in hospital and clinical lab settings for respiratory, sexual health, and infectious disease testing.

TypeBroad incumbent
Description

BD is a broad incumbent in molecular diagnostics and life sciences with the BD MAX system and a large reagent portfolio, overlapping with Meridian's clinical diagnostics and OEM reagent businesses across multiple disease areas.

TypeBroad incumbent
Description

Roche Diagnostics is the largest IVD player globally and a broad incumbent with cobas molecular systems, a comprehensive reagent portfolio, and proprietary chemistries that compete across Meridian's reagent and diagnostics segments.

TypeBroad incumbent
Description

QuidelOrtho is a broad incumbent in immunoassays and rapid diagnostics, competing with Meridian's Curian, Immunocard, and Premier immunoassay platforms and serving similar hospital and clinical laboratory customers.

TypeEmerging player
Description

LGC Biosearch Technologies is a specialty reagent provider in molecular biology, NGS, and oligonucleotides — an emerging competitor with partial overlap to Meridian's qPCR, NGS enzyme, and OEM reagent product lines.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A5 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Meridian Bioscience

In Vitro Diagnosticsmeridianbioscience.com

Meridian Bioscience firmographics

Firmographics
Name
Meridian Bioscience
Legal name
Meridian Bioscience
Website
https://meridianbioscience.com
Company type
Private
Founded year
1981
Operating status
Operating
Headcount range
501–1,000 employees
Ownership category
akta.pro rank

Meridian Bioscience industry classification

Industry
Product category
In Vitro Diagnostics
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
akta.pro secondary industry
Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

  • Molecular diagnostic reagents
  • QPCR master mixes
  • Antigens and antibodies
  • In vitro diagnostics
  • Immunoassay platforms

Where Meridian Bioscience is headquartered

Location

Headquarters

HQ city
Cincinnati
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Meridian Bioscience business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Molecular Reagents and Enzymes: Meridian offers molecular diagnostic reagents including qPCR master mixes, isothermal amplification reagents, NGS enzymes, and related enzymes sold to diagnostic manufacturers for incorporation into their test kits
  2. Antibodies and Antigens: Portfolio of over 3,000 antigens and antibodies covering more than 500 disease targets, sold to diagnostic manufacturers and assay developers
  3. Diagnostic Platforms and Tests: Meridian manufactures and sells diagnostic platforms including molecular (Revogene, Alethia), immunoassay (Curian, Immunocard STAT), urea breath testing (BreathID), and blood chemistry (LeadCare) systems along with associated test reagents
  4. Contract Manufacturing Services: Provides custom antibody and protein manufacturing services, and IVD contract manufacturing for diagnostic developers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Meridian Bioscience product offering

Product offering

Core offering

Meridian Bioscience is a fully integrated life science company that develops, manufactures, and distributes diagnostic test kits and raw materials. The Life Science division supplies molecular reagents (qPCR/RT-qPCR master mixes, NGS enzymes, isothermal amplification reagents) and over 3,000 antigens and antibodies covering 500+ disease targets to diagnostic manufacturers. The Diagnostics division sells proprietary diagnostic platforms including Revogene, Alethia, BreathID, Curian, Immunocard, Premier, and LeadCare for clinical testing of gastrointestinal, respiratory, pediatric, and sexual health conditions.

Product overview

Meridian Bioscience is a fully integrated life science and diagnostic company operating in over 70 countries. The company offers two main divisions: Life Science and Diagnostics. The Life Science division provides molecular and immunological reagents for diagnostic manufacturers, including over 3,000 antigens and antibodies covering more than 500 disease targets, specialty qPCR/RT-qPCR master mixes, molecular enzymes, nucleotides, and NGS reagents. The Diagnostics division offers diagnostic platforms and tests including molecular platforms (Revogene and Alethia), urea breath testing platforms (BreathID Hp Lab, BreathID Smart, BreathID Hp), immunoassay platforms (Curian, Immunocard STAT, Immunocard, Premier, Tru, Merifluor), and blood chemistry platforms (LeadCare). The product portfolio covers disease areas including gastrointestinal (H. pylori, C. difficile, rotavirus, adenovirus), respiratory (COVID-19, flu, pertussis, RSV), pediatric/neonatal (CMV, Group B Strep, lead poisoning), and sexual health (chlamydia, gonorrhea, HIV, HSV, HCV). Meridian's molecular reagents include liquid ambient-stable master mixes, lyophilization-ready (Lyo-Ready) and air-dryable formulations, specimen-specific inhibitor-tolerant mixes, and NGS library preparation solutions. All molecular reagents are manufactured under ISO13485 regulations.

Differentiator

Problem solved

Functional benefit

Brands

  • Meridian Bioline: Trusted brand by leading molecular companies, antibody companies, and diagnostic manufacturers worldwide for human diagnostics, environmental testing, and veterinary diagnostics.

Products and services

  • Revogene A molecular diagnostic platform used for respiratory and infectious disease testing, including a viral respiratory testing panel. Designed for clinical laboratories.
  • Alethia A molecular diagnostic platform with IVDR-certified assays for pertussis, GBS, CMV, malaria, chlamydia, gonorrhea, and HSV 1&2. Sold to clinical laboratories and hospitals.
  • BreathID Hp Urea breath testing platform for H. pylori diagnosis, used by hospitals and clinical laboratories.
  • BreathID Smart Urea breath testing platform for point-of-care H. pylori detection.
  • BreathID Hp Lab Urea breath testing platform for H. pylori detection in laboratory settings.
  • Curian Immunoassay diagnostic platform for clinical testing.
  • Immunocard STAT Immunoassay platform for rapid diagnostic testing.
  • Immunocard Immunoassay platform for diagnostic testing.
  • Premier Immunoassay diagnostic platform.
  • Tru Immunoassay platform for diagnostic testing.
  • Merifluor Immunoassay platform for diagnostic testing.
  • LeadCare Blood lead testing platform for pediatric and environmental lead poisoning screening.
  • Para-Pak Sample collection and transport products for diagnostics.
  • Antibodies and Antigens Portfolio Over 3,000 antigens and antibodies covering more than 500 disease targets including allergens, autoimmune markers, cancer markers, infectious disease antigens, and more. Sold to diagnostic manufacturers and assay developers.
  • Liquid Ambient-Stable Master Mixes qPCR master mixes including Liquid Stable Flex DNA qPCR Mix and Liquid Stable Ready DNA qPCR Mix, providing 12+ months ambient-temperature stability for diagnostic kit manufacturers.
  • Specimen-Specific Inhibitor Tolerant Master Mixes Sample-specific qPCR and RT-qPCR formulations for direct amplification from crude lysates or inhibitor-rich samples including blood, saliva, urine, stool, and tissue.
  • Lyo-Ready and Air-Dryable Master Mixes Glycerol-free formulations including Lyo-Ready qPCR Mix, Air-Dryable qPCR Mix, Lyo-Ready 1-Step RT-qPCR Mix, and Lyo-Ready LAMP Mix, compatible with lyophilization and air-drying for room temperature shipping.
  • Isothermal Amplification Reagents LAMP, NASBA, and other isothermal amplification reagents including Bst DNA Polymerase for point-of-care diagnostics in resource-limited regions.
  • Glycerol-Free NGS Enzymes Glycerol-free enzymes for NGS library preparation enabling sequencing kits that can be shipped and stored at ambient temperature. Includes a Lyophilized NGS Library Preparation Kit with 12-month ambient stability.
  • Molecular Enzymes Includes Taq DNA Polymerase, MMLV-RT reverse transcriptase, and Glycerol-Free Taq HS DNA Polymerase for PCR/qPCR and reverse transcription applications.
  • Custom Antibody and Protein Manufacturing Services Custom antibody and protein manufacturing services, plus IVD contract manufacturing for diagnostic developers.

Quantifiable outcome

  • 12+ months ambient temperature stability for liquid master mixes
  • +1 more outcomes

Companies that use Meridian Bioscience

Customer profile

Segments3 records

Ideal customer profiles1 record

Meridian Bioscience technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Meridian Bioscience partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • 4basescoreStrategic or Co-development Partner · 1 January 2026Meridian Bioscience and 4bases announced collaboration to enable rapid, globally scalable next-generation sequencing workflows. This partnership aims to advance molecular diagnostics capabilities through combined expertise in reagents and sequencing technologies.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Meridian Bioscience competitors and assessment

Company assessment

Direct peers

  • Hologic: Hologic is a molecular diagnostics company whose Panther system and assay menu compete with Meridian's Revogene and Alethia molecular diagnostic platforms in clinical laboratories for infectious disease testing.
  • Bio-Rad Laboratories: Bio-Rad is a major manufacturer of molecular biology reagents, qPCR master mixes, and clinical diagnostics — directly comparable to Meridian's life science reagent and diagnostics businesses across both OEM and end-user channels.
  • QIAGEN: QIAGEN is a global leader in molecular diagnostics and sample-prep reagents, directly competing with Meridian's PCR/qPCR reagents and NGS enzyme offerings and serving similar diagnostic manufacturer and laboratory customers.
  • New England Biolabs (NEB): NEB is a leading developer and manufacturer of molecular biology enzymes and reagents, including polymerases, master mixes, and isothermal amplification tools — a direct competitor to Meridian's molecular reagent portfolio.
  • Promega Corporation: Promega supplies molecular biology reagents, enzymes, and antibodies to life science researchers and diagnostic manufacturers, with overlapping product lines in qPCR reagents, NGS enzymes, and immunoassay components comparable to Meridian's offerings.
  • Cepheid (Danaher): Cepheid's GeneXpert molecular diagnostic system competes directly with Meridian's Revogene platform in hospital and clinical lab settings for respiratory, sexual health, and infectious disease testing.

Broad incumbents

  • Becton, Dickinson and Company (BD): BD is a broad incumbent in molecular diagnostics and life sciences with the BD MAX system and a large reagent portfolio, overlapping with Meridian's clinical diagnostics and OEM reagent businesses across multiple disease areas.
  • Roche Diagnostics: Roche Diagnostics is the largest IVD player globally and a broad incumbent with cobas molecular systems, a comprehensive reagent portfolio, and proprietary chemistries that compete across Meridian's reagent and diagnostics segments.
  • QuidelOrtho: QuidelOrtho is a broad incumbent in immunoassays and rapid diagnostics, competing with Meridian's Curian, Immunocard, and Premier immunoassay platforms and serving similar hospital and clinical laboratory customers.

Emerging players

  • LGC Biosearch Technologies: LGC Biosearch Technologies is a specialty reagent provider in molecular biology, NGS, and oligonucleotides — an emerging competitor with partial overlap to Meridian's qPCR, NGS enzyme, and OEM reagent product lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Meridian Bioscience social profiles

Digital presence

Meridian Bioscience compliance and trust

Trust signal

Compliance2 records

Meridian Bioscience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Meridian Bioscience leadership team

Management profile

Number of profiles

Profiles6 records

Meridian Bioscience subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Meridian Bioscience funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Meridian Bioscience M&A and investment

M&A and investment

M&A5 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Meridian Bioscience

What does Meridian Bioscience do?

Meridian Bioscience is a fully integrated life science company that develops, manufactures, and distributes diagnostic test kits and raw materials. The Life Science division supplies molecular reagents (qPCR/RT-qPCR master mixes, NGS enzymes, isothermal amplification reagents) and over 3,000 antigens and antibodies covering 500+ disease targets to diagnostic manufacturers. The Diagnostics division sells proprietary diagnostic platforms including Revogene, Alethia, BreathID, Curian, Immunocard, Premier, and LeadCare for clinical testing of gastrointestinal, respiratory, pediatric, and sexual health conditions.

Is Meridian Bioscience a public or private company?

Meridian Bioscience is a private company. It is classified as private equity controlled and is currently operating.

When was Meridian Bioscience founded?

Meridian Bioscience was founded in 1981. It employs 501 to 1,000 people.

Where is Meridian Bioscience based?

Meridian Bioscience is headquartered in Cincinnati, United States, in the North America region.

How does Meridian Bioscience make money?

Four revenue lines are on record. Molecular Reagents and Enzymes are the primary driver. The others are antibodies and Antigens, diagnostic Platforms and Tests and contract Manufacturing Services.

Who are Meridian Bioscience's main competitors?

Direct peers on record are Hologic, Bio-Rad Laboratories, QIAGEN, New England Biolabs (NEB), Promega Corporation and Cepheid (Danaher). Broad incumbents are Becton, Dickinson and Company (BD), Roche Diagnostics and QuidelOrtho. LGC Biosearch Technologies is listed as an emerging player.

Does Meridian Bioscience have an API?

No public API is recorded for Meridian Bioscience.

What industry is Meridian Bioscience in?

Meridian Bioscience's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpaceMeridian Bioscience Announces Health Canada License for Alethia® CMV AssayMeridian Bioscience announced Health Canada granted a license for its Alethia CMV assay, expanding its Alethia menu. The assay uses LAMP technology for rapid detection, targeting congenital CMV, which affects 1 in 200 newborns. It enables early detection via saliva samples.Financial PostMeridian Bioscience Announces Health Canada License for Alethia® CMV AssayMeridian Bioscience has received Health Canada licensing approval for its Alethia® CMV assay, a molecular diagnostic test for detecting congenital cytomegalovirus in newborns. The clearance expands Meridian's existing Alethia menu in the Canadian market, adding CMV testing to a platform that uses LAMP isothermal amplification technology for rapid molecular detection. The company highlighted that the test uses saliva specimens and enables early detection of CMV, which affects approximately 1 in 200 babies born annually.FinancialContent Business PageMeridian Bioscience Announces Health Canada License for Alethia® CMV AssayMeridian Bioscience announced that Health Canada has granted a license for its Alethia® CMV assay, expanding the company's molecular diagnostic offerings in the Canadian market. The assay enables early detection of congenital cytomegalovirus using saliva samples, addressing a condition affecting 1 in 200 babies born annually with nearly 1 in 4 women carrying the virus. The Alethia platform uses LAMP technology to deliver accurate molecular results in less than an hour.MorningstarMeridian Bioscience Announces Health Canada License for Alethia® CMV AssayMeridian Bioscience announced Health Canada granted a license for its Alethia CMV assay, expanding its Alethia menu. The assay uses LAMP technology for rapid detection, with nearly 1 in 4 women carrying CMV and 1 in 200 babies born with congenital CMV.Business Wire BlogMeridian Bioscience Announces Health Canada License for Alethia® CMV AssayMeridian Bioscience has received Health Canada licensing for its Alethia® CMV assay, expanding the company's molecular diagnostic portfolio in the Canadian market. The assay uses LAMP technology and saliva samples to enable rapid, sensitive detection of cytomegalovirus, the most common congenital infection transmitted from mother to baby during pregnancy. The clearance allows Meridian to offer early congenital CMV testing to healthcare providers across Canada.GlobeNewswireUnlocking Growth in the Sweden Flu Market: The Rise of Molecular Diagnostics and Targeted Antiviral TherapiesThe Sweden flu diagnostic and treatment market is projected to grow from USD 172.1 million in 2026 to USD 210.3 million by 2031, representing a 4.1% compound annual growth rate. This growth is driven by the high clinical burden of influenza among seniors aged 65 and above, who account for the majority of influenza-related deaths, alongside increasing adoption of molecular diagnostics and updated national antiviral treatment guidelines including baloxavir. The market operates within Sweden's centralized, publicly funded healthcare system and is dominated by multinational diagnostics and pharmaceutical companies including Roche, Thermo Fisher Scientific, 3M, and Meridian Bioscience, with key challenges including seasonality, EU regulatory compliance, and supply chain dependencies.BioSpaceMeridian Bioscience and 4bases Announce Collaboration to Enable Rapid, Globally Scalable Next-Generation Sequencing WorkflowsMeridian Bioscience and 4bases announced a collaboration to stabilize KaryoSolver, a next-generation cytogenetics assay, using lyophilization. The ambient-stable reagents eliminate cold-chain requirements, enabling global distribution and scalable production. The companies will showcase the collaboration at ESHG in June and ADLM in July.Business Wire BlogMeridian Bioscience and 4bases Announce Collaboration to Enable Rapid, Globally Scalable Next-Generation Sequencing WorkflowsMeridian Bioscience and 4bases announced a collaboration to stabilize KaryoSolver, a next-generation cytogenetics assay, using lyophilization to enable ambient-temperature shipping and storage. The partnership removes cold-chain requirements, extending shelf life and simplifying global distribution. Both companies will exhibit at ESHG and ADLM 2026.Business Wire BlogMeridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay PortfolioMeridian Bioscience announced that its Alethia molecular assay portfolio has achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR), with certification issued by Notified Body GMED. The portfolio includes assays for pertussis, GBS, CMV, malaria, chlamydia, gonorrhea, and HSV 1&2, all classified as Class C under IVDR. This certification enables Meridian to maintain uninterrupted product availability and regulatory compliance across the European market during the industry-wide transition to more rigorous IVDR requirements.BioSpaceMeridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay PortfolioMeridian Bioscience announced that its Alethia molecular assay portfolio has achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746, with certification issued by Notified Body GMED (0459), covering assays for pertussis, GBS, CMV, malaria, chlamydia, gonorrhea, and HSV 1&2. The portfolio has been classified as Class C under IVDR, which introduces more rigorous requirements for clinical evidence, performance evaluation, quality systems, and post-market surveillance. CEO Andy Kitzmiller stated that the transition to IVDR represents one of the most demanding regulatory shifts the industry has faced, and the certification ensures uninterrupted product availability for European customers during the transition.